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Abstract 
 
THE EFFECT OF TEMPERATURE ON THE TRANSDERMAL ABSORPTION OF 
ANTHRACENE IN HEALTHY INDIVIDUALS 
 
Killian Wustrow 
B.A., Wake Forest University 
M.A., Appalachian State University 
 
 
Chairperson:  Caroline Smith  
 
 
  
The respiratory routes of exposure to hazardous chemicals such polycyclic aromatic 
hydrocarbons among occupational groups such as coal tar workers, firefighters, and asphalt 
workers has been well studied; however, the contribution to dermal routes of exposure has 
remained understudied. Microdialysis (MD) is an intradermal sampling technique allowing 
bidirectional exchange of substances between the MD fiber and interstitial fluid, depending on 
concentration gradient and pressure. To determine if a noncarcinogenic PAH, anthracene, can 
be dermally absorbed and sampled via MD, multiple MD fibers were inserted into the ventral 
forearm and a 2.0% anthracene solution was applied over the sites.  Dialysate from the MD 
fibers were sampled over 4 hours at a rate of 1 µL/min. The dialysate was measured using 
liquid chromatography and tandem mass spectrometry. Anthracene concentration in the 
dialysate samples was similar between the hot and thermoneutral sites (P = 0.263), with values 
of 2.9 ± 0.4 ppm and 3.5 ± 0.4 ppm respectively. Absolute SkBF (flux) was significantly higher 
at the heated versus the thermoneutral site (P =0.001) with values of 35.7 ± 11.8 and 7.2 ± 1.0, 
respectively; however, values were not significantly different between sites when presented as 
 v 
a percentage of maximum cutaneous vascular conductance (%CVCmax; P= 0.057) with values 
of 29.2 ± 8.3 and 8.6 ± 2.3, respectively.  To our knowledge, this is the first protocol to examine 
dermal absorption of a PAH in vivo using MD.  
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Chapter 1 
Introduction 
Approximately 345,600 career and 814,850 volunteer fire fighters in the USA dedicate 
their lives administering aid and suppressing fires (21). Previous researchers have observed 
greater cancer incidence among fire fighters including excess myeloma, non-Hodgkin’s 
lymphoma, prostate and testicular cancer, compared to the general population (3, 14, 31, 41). 
Smoke from a structure burn contains a variety of organic materials resulting from the 
incomplete combustion of materials within the structure (24). These organic materials include 
many polycyclic aromatic hydrocarbons (PAHs), many of which have been identified as 
carcinogenic or potentially carcinogenic. During fire suppression, fire fighters wear turnout 
gear compliant to the National Fire Protection Association which includes a self-contained 
breathing apparatus (SCBA). The SCBA comprises a respirator with a full face mask that 
provides a skin and respiratory protection factor greater than 10,000, which should eliminate 
inhalation exposure to combustion products (3, 7). Despite this high level of protection, fire 
fighters do not appear to be completely protected from these hazardous chemicals including 
benzene and PAHs (17). Routes of exposure have been proposed as either re-breathing of 
PAHs when the apparatus is removed or dermal absorption during the fire suppression itself.  
Respiratory routes of exposure have received more attention than dermal absorption of 
the hazardous chemicals from fire suppression. While the skin serves as a barrier between the 
body and the environment, some substances penetrate the skin with relative ease. The structure 
of the epidermis is a complex “brick and mortar” due to the stratum corneum. This structure 
acts as a barrier that very selectively prevents hydrophilic chemicals from passing through the 
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epidermis. Lipophilic compounds tend to permeate through the lipid matrix of the stratum 
corneum and into the interstitial fluid and eventually the blood stream (37, 43). One important 
consideration regarding the putative dermal absorption of PAH’s in firefighters is the heat 
strain experienced during fire exposure and the associated increases in skin temperature (Tsk) 
and absorptive properties of the dermis. Several studies have examined the effects of 
temperature on dermal absorption of topically applied substances, focusing on maximizing 
absorption of pharmacologics. Increased skin temperature (Tsk) has been shown to increase 
permeability of various chemicals including lidocaine and fentanyl, with associated increases 
in skin blood flow (SkBf) further contributing to larger amounts of transdermal absorption and 
clearance of certain drugs versus thermoneutral conditions (20, 36-38, 44, 46, 63). Fire fighters 
are exposed to extremely high ambient temperatures as high as 200°C (59) during live fires 
and training exercises resulting in high cardiac output, SkBf and sweating rates to meet 
metabolic and thermoregulatory demands. Several studies have reported the presence of 
carcinogens on the skin surface of firefighters following fire exposure (2, 3, 12, 13), therefore 
increase Tsk and SkBf may exacerbate dermal absorption of carcinogens as a potential route of 
exposure.  
Currently, the specific route of carcinogen exposure in firefighters is unclear when 
considering the use of protective clothing (12). PAH’s or their metabolites have been identified 
in dermal swabs, blood, breath, and urine samples, yet, no studies have fully elucidated the 
mechanism of exposure. To further examine dermal absorption as a putative route of exposure, 
intradermal microdialysis may be employed. Microdialysis allows for a bidirectional exchange 
of substances between the microdialysis (MD) fiber and interstitial fluid, depending on 
concentration gradient and pressure. As an initial proof of concept, a non-carcinogenic PAH, 
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anthracene, will be applied to an area of the skin of healthy human subjects to determine; 1) 
PAHs can be sampled and measured via intradermal microdialysis and 2) PAH’s are dermally 
absorbed, and 3) skin temperature alters dermal absorption of anthracene. 
 
Problem Statement 
 The purpose of this study is to examine the effect of varying skin temperatures on the 
dermal absorption of anthracene in a healthy population (18-65 years old) via microdialysis 
sampling and diasylate analysis.     
Aim 1: To determine the efficacy of microdialysis as a technique for interstitial fluid 
sampling and recovery of the lipophilic compound anthracene by conducting a two-phase pilot 
study to ensure an adequate flow rate for anthracene recovery from interstitial fluid. 
Hypothesis: It is hypothesized that flow rates of 1uL/min will allow recovery of 
anthracene from the interstitial fluid, and that anthracene may be successfully measured via 
mass spectrometry.  
Aim 2: To determine the effect of skin temperature on dermal absorption of one non-
carcinogenic PAH, anthracene, sampled via intradermal microdialysis.  
Hypothesis: It is hypothesized that significantly higher concentrations of anthracene 
will be observed with increasing skin temperature due to enhanced transdermal absorption.  
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Summary 
 Fire fighters are exposed to many potentially hazardous chemicals during fire 
suppression including PAHs. Although there are strict standards of protection to limit 
exposure, evidence indicates the presence of hazardous chemicals on the skin surface and of 
metabolites in body fluids of fire fighters. With such strict protection standards, dermal 
absorption of these carcinogenic compounds may potentially be a route of exposure in fire 
fighters. Microdialysis is a technique that allows for the sampling of the interstitial fluid of the 
subcutaneous tissue. To assess the amount of absorption of such compounds, anthracene will 
be applied to the ventral forearm of healthy subjects and microdialysis will be utilized for 
sampling of the interstitial fluid. Fire fighters are exposed to high temperatures which has been 
shown to increase the amount of dermal absorption of some substances. In the present study, 
skin on the ventral forearm will be locally heated during the experimental phase of the protocol 
to determine the effect of temperature on absorption of the PAH anthracene. The protocol 
development to determine the amount of absorption of these lipophilic compounds will be used 
in future studies to assess absorption of these PAHs in fire fighters in the field during fire 
suppression. 
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Chapter 2 
Review of Literature 
2.1  Background 
 It has been established that fire fighters are exposed to a variety of different chemicals 
during fire suppression including polycyclic aromatic hydrocarbons (PAHs) (3, 7, 17, 26). 
These PAHs have been classified as either carcinogenic, probably carcinogenic, or possibly 
carcinogenic to humans by the International Agency for Research on Cancer (IARC) (25). Fire 
fighters wear turnout gear and a self-contained breathing apparatus (SCBA) which should 
eliminate the inhalation exposure to these carcinogenic compounds. Nevertheless, some 
studies have found that fire fighters have elevated risk for multiple types of cancers (14, 26, 
31, 55). Metabolites of carcinogens have been found in urine and blood, with respiratory 
rebreathing or dermal absorption as potential routes for exposure. Dermal carcinogen 
absorption has received limited attention compared to respiratory routes due to the challenges 
with measurement in vivo. Further, there are many factors affecting dermal absorption 
including the structure of the skin, the physical properties of the chemical, and many 
physiological responses. These factors determining dermal absorption will be explored in the 
following review.   
 
2.1.1  Skin Anatomy and Physiology 
The skin is the largest organ of the human body and provides the most protection from 
the external environment (32). This protection includes regulating which substances enter and 
exit the body through the skin. Skin is comprised of three layers: the epidermis, the dermis and 
the hypodermis. Functionally, the epidermis is impermeable to water and therefore serves to 
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conserve water in the body and prevent harmful water-soluble substances from diffusing 
through the skin. This remarkable ability to act as a barrier is attributed to the outer layer of 
the epidermis, the stratum corneum (43). Unlike many other structures, the stratum corneum 
consists of corneocytes interspersed throughout the extracellular matrix of lipids (40). With 
this milieu of lipid-infused extracellular matrix, the skin remains largely impenetrable to 
hydrophilic compounds but will allow for the diffusion and storage of lipophilic compounds. 
This structure prevents the loss of water from the body and act as a barrier to many topically 
applied drugs (16).  
 
2.1.2 Factors Affecting Dermal Absorption  
The permeability of the skin can be altered both chemically and physically with 
alterations in the skin structure allowing a chemical to pass more easily through the skin. 
Research has shown that many chemical enhancers will interact with the lipid matrix of the 
stratum corneum to enhance delivery. Solvents such as ethanol and methanol extract lipids 
from the stratum corneum, causing the corneocytes to expand or for gaps to occur between the 
cells which allows for greater absorption (16, 60). Iontophoresis and photomechanical waves 
(PW), or high amplitude pressure pulses generated during ablation by high-power lasers, have 
been shown to increase the rate of dermal drug delivery. While iontophoresis mainly acts on 
the charge of the chemical applied to the skin to add a driving force into the stratum corneum 
(27), PW have been shown to enhance transport of molecules through the stratum corneum by 
increasing its permeability (34).  
Research indicates that the transdermal delivery of many chemicals is enhanced with 
elevated skin temperature (2, 20, 37, 44, 53, 54, 65). A body of research has demonstrated that 
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increased temperature, either locally and/or systemically, increases the delivery of drugs and 
other substances. Petersen and colleagues (38) locally clamped Tsk at 43°C in healthy male 
subjects during application of a nicotine patch on their arm. The locally elevated Tsk of 43°C 
resulted in enhanced nicotine uptake compared a thermoneutral Tsk temperature of 32°C (38). 
Human studies have indicated an increased penetration of harmful chemicals using heat 
application techniques such as sauna, heated water baths and exercise-induced hyperthermia 
(2, 18, 28, 33). The increase in Tsk elicits a restructuring of the lipid matrix resulting in greater 
absorption of some chemicals. A significantly greater plasma concentration of lidocaine was 
observed when locally heated lidocaine patches were applied to the skin of healthy volunteers 
for 2, 4, and 12 hours versus non-heated patch application (33). A drug study involving the 
absorption of a transdermal fentanyl delivery system (fentanyl TDS) found that application 
through a controlled heat-assisted drug Delivery (CHADD) patch (a patch that produces local 
heat for several hours to increase skin temperature) increased peak plasma concentration (46) 
versus no heating. Further, significantly increased peak plasma concentrations of testosterone 
(939 ng/dL) have been observed when a heat-generating patch of testosterone was applied to 
the skin of six healthy adults compared to those with a patch with no heat (635 ng/dL). 
In more applied environments, when exposed to hot environments, systemic 
thermoregulatory responses are stimulated to dissipate heat through cutaneous vasodilation and 
sweating, likely altering absorption characteristics (9, 10). Firefighters can be exposed to 
environmental temperatures greater than 200°C (42) which significantly increases cutaneous 
vasodilation, cardiac output, and elicits high sweating rates in an attempt to reduce the 
increasing Tcore and Tsk. During fire suppression, fire fighters experience significantly elevated 
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Tsk, Tcore and cardiac output in response to extreme environmental temperatures, which could 
enhance the ability of the PAHs to penetrate through the skin and into circulation. 
 A further factor that may influence the microclimate of the skin and potentially dermal 
absorption is the presence of fluid on the skin surface. The human body primarily relies on 
heat dissipation through evaporation of sweat in hot environments and during exercise, with 
increasing sweating rate at higher workloads and more extreme temperatures. Firefighters 
experience higher rates of sweat loss during active duty (2950 ± 1034 mL of water in hot 
conditions vs. 1290 ± 525 mL in control conditions) (30), which may influence dermal 
properties, clothing and spreading of carcinogens over the skin surface. A body of research has 
documented a non-uniform pattern of sweating rates between different sites, making this a 
potential consideration for site sampling. Patterns of regional sweating rates in a study utilizing 
male athletes exercising at varied intensities (49) observed (a) sweat rates increased with 
increased exercise intensity in all regions of the body, (b), the posterior torso exhibited the 
greatest increase across all intensities (the only exception being the forehead), (c) and an 
increase in sweat rate from proximal to distal regions on the arms.  Although overall sweat 
rates were significantly higher in males compared to females, similar regional sweat rate 
patterns were observed. Selection of sampling sites should therefore be carefully considered, 
recognizing potentially exposed skin sites, SkBf, and regional sweating rates.  
 
2.3  Interstitial Sampling Via Intradermal Microdialysis  
Microdialysis (MD) is an in vivo technique that allows for continuous sampling of the 
dermal extracellular space (22, 35, 39). The MD technique requires a microdialysis probe, 
microperfusion pumps, a perfusion fluid and a sampling device (39). The semipermeable 
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membrane is surrounded by a copper guide wire, with an exposed portion (~1cm) of the 
membrane placed intradermally in the extracellular space to sample the interstitial fluid (ISF). 
This allows for bidirectional flow between the perfusate and IF, and depending on the 
concentration gradient, can either deliver or sample chemicals in the IF (22). MD has been 
widely utilized to examine diverse research problems including sampling neurotransmitter 
release in the interstitial fluid to examine the pathophysiology of neurological disorders (23, 
47). MD has also proven effective in delivering chemicals to the interstitial fluid to examine 
cell signaling pathways concerned with cutaneous microvascular function (12, 13, 48).   
The recovery of a substance from the IF via MD is influenced by many factors 
including pore diameter of the fiber, perfusion rate, molecular size, and charge of the substance 
(15). Lower perfusion rates tend to yield more diffusion of compounds into the perfusate but 
lower the amount of sample collected. High perfusion rates allow for a higher sample amount 
but decrease the recovery of substances form the ISF. The ideal perfusion rate for adequate 
sample size and adequate sampling recovery was found to be 0.5-1.0 uL/min (15). The lower 
the molecular weight, the higher the recovery of the dialysate, therefore, a drug or chemical 
which will be topically delivered must be of a lower molecular weight. All these factors must 
be carefully considered when determining the suitability of intradermal MD for sampling or 
delivery. 
 
2.5  Polycyclic Aromatic Hydrocarbons  
PAHs are a result of the incomplete combustion of items found in houses and from the 
burning of the structures themselves. A variety of PAHs are also found in soil due to 
contamination from long-range transport (58), as well as the production of coal tar and asphalt 
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(61). There are a variety of these compounds and many of them have been classified as 
carcinogenic corresponding to exposure level and time. A meta-analysis observed a rising 
increase of developing cancers such as multiple myeloma, non-Hodgkin’s’ lymphoma, prostate 
and testicular cancer among petrochemical refinery workers and other occupations involving 
exposure to PAHs (31). A variety of PAHs such as benz[a]anthracene and benzo[a]pyrene have 
been shown to cause tumorigenesis in mice (4). Studies performed through NIOSH indicate 
the contamination of SCBAs with PAHs after only 25 minutes of use during fire suppression. 
The presence of these toxic chemicals has been found both on and underneath the protective 
turnout gear (62). Dermal absorption rates have been analyzed through skin swipes and areas 
of thicker skin appear to be more protective than areas of thinner skin (57). 
 To assess the ability to recover and analyze the presence of the PAHs through a route 
of dermal exposure, a chemical that is similar in structure to these carcinogenic compounds to 
which firefighters and other workers are exposed need to be considered. Anthracene is a 
nonmutagenic, noncarcinogenic PAH with a relatively low molecular weight that is present in 
the environment. While many PAHs are classified as either carcinogenic or possibly 
carcinogenic, anthracene itself is not considered by the NTP to be problematic in developing 
cancer in either animal or human models. Anthracene is not classified as carcinogenic and has 
a relatively low molecular weight which makes it a good candidate for the present study to test 
dermal absorption through the skin into MD fibers.  
 
2.6  Summary 
Despite personal protective equipment including turnout gear and SCBA, firefighters are 
exposed to highly carcinogenic compounds produced as byproducts of incomplete combustion. 
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Increases in ambient temperature, skin temperature, and skin blood flow have all been shown 
to increase delivery of many chemicals through the skin. To determine if transdermal 
absorption is a likely route of absorption of carcinogenic molecules, intradermal MD will be 
utilized to sample recovery of a topically applied non-carcinogenic PAH in the interstitial fluid 
at thermoneutral and warm local skin temperatures.  
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Chapter 3 
Methods 
3.1 Subjects 
The subjects were recruited from Appalachian State University and the community of 
Boone through flier advertisements and email listserves. The subjects were healthy males and 
females aged 18-65 years old. Subjects were nonsmokers with no metabolic, cardiovascular or 
uncontrolled dermatological conditions. Females of reproductive age completed a pregnancy 
test and were excluded if positive. 
 
3.2 Exclusion Criteria  
Individuals with skin conditions including eczema, rashes, or disorders of pigmentation 
were excluded from the study as skin conditions that disrupt the normal structure of the dermis 
may alter the rate of absorption.  
 
3.3 Experimental Techniques 
Methods were developed for dermal delivery and recovery of anthracene (ANT). 
Intradermal microdialysis was utilized for the recovery of ANT from the interstitial fluid, 
following dermal application and detected via fluorescence and mass spectrometry (MS). 
Fluorescence was utilized in initial pilot studies simply to detect the presence of ANT in the 
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dialysate samples and MS was utilized by collaborators at North Carolina State University 
during the latter stages of pilot testing and experimental protocols for detection and 
quantification of ANT in the dialysate. These experimental techniques are outlined below. All 
procedures were approved by the Appalachian State University Institutional Review Board and 
the use of pharmacologics were approved by the Food and Drug Administration (FDA). 
 
3.3.1 Intradermal Microdialysis 
Subjects were instrumented with two intradermal microdialysis (MD) fibers (10-mm, 
30-kDa cutoff membrane, MD 2000; Bioanalytical Systems, West Lafayette, IN) placed in the 
left ventral forearm using sterile technique. Insertion and exit points were marked on the skin, 
which was cleaned with alcohol and betadine (51). MD fibers were kept at least 2 cm apart to 
prevent interference between the local heating units or any cross-contamination. Prior to MD 
fiber placement, ice was applied to the MD sites for 5 minutes to temporarily anesthetize the 
skin. A beveled 25-gauge needle was inserted horizontally into the intradermal layers such that 
the entry and exit sites were roughly 1.5 cm apart. MD fibers were then threaded through the 
lumen of the guide needle, and the needle was removed leaving the MD fiber in place. The 
MD fibers were perfused with lactated Ringer’s solution with 10% 2-hyroxypropyl-β-
cyclodextrin (HBC). HBC increases the solubility of lipophilic drugs because of a complex 
created between the drug and the lipophilic cavity of the HBC. The HBC was mixed 
immediately before usage, dissolved in lactated Ringer solution and sterilized with syringe 
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microfilters (Acrodisc; Pall, Ann Arbor, MI). During the insertion trauma resolution period 
(~60 min), the solution was perfused through the MD fibers at a rate of 1 µL/min.  
 
3.3.2. Fluorescence  
For each of the pilot experiments involving fluorometry, an ANT standard curve was 
made for which sample values could be compared to and quantified. These calculations helped 
derive an estimate of the amount of ANT in any given sample and helps to reduce the baseline 
noise from the fluorometer. 
A spreadsheet was created with wavelengths from the emission spectra and the intensity 
in counts per second for the 1 parts per billion (ppb), 10 ppb and 100 ppb anthracene standards. 
Using the 1 ppb spectra as a baseline, the 1 ppb intensity was subtracted from the 10 ppb and 
the 100 ppb to get a 9 and 99 ppb emission spectrum, respectively. The maximum and 
minimum fluorescence was found for the 9 and 99 ppb anthracene spectrum. 
The averages of the peaks were subtracted out of the 9 ppb baseline and divided by the 
concentration (9 or 99 ppb) to give conversion factor of average fluorescence per ppb. This 
was then used to estimate the amount of ANT in a sample. The same formulas were used to 
subtract a solvent baseline from spectra from the dialysate samples. The conversion factors 
found above were then used to estimate the amount of ANT in the sample based on the amount 
of fluorescence. 
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3.3.3. Mass Spectrometry 
Mass spectrometry (MS) is an analytical technique that is highly sensitive and versatile, 
which allow the detection of specific substances within a simple or complex matrix. 
Collaborators at North Carolina State University, under the guidance of Dr. Nelson Vinueza, 
developed a quantitative method via tandem mass spectrometry  to measure anthracene from 
dialysate samples of this study (6, 19).  
All experiments were performed on a Velos Pro linear ion trap mass spectrometer 
(Thermo Fisher Scientific) coupled to a Ultimate 3000 UHPLC system. Samples were 
introduced via autosampler and the injection volume was set to 10 μL. The mobile phase was 
made up by an isocratic elution of acetonitrile and water at a ratio of 9:1. The system was 
configured to bypass the column and the total run time for each sample was 5 minutes. 
Ionization was performed on positive mode via an atmospheric-pressure chemical ionization 
(APCI) source. Targeted tandem mass spectrometry (MS/MS) was utilized to select and 
fragment the analyte (anthracene) and internal standard (deuterated anthracene) ions. The 
matrix ions fragment differently than the analyte and internal standard ions, since they are a 
different class of compounds. It is straightforward then to monitor only the product-ions of the 
analyte and internal standard, which are typically formed by acetylene-loss ([M – C2H2]+•). 
Product-ion monitoring differentiates the analyte and internal standard from surrounding 
matrix ions, offering a simpler spectrum with higher sensitivity. 
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3.3.3.1 Preparation of Standard Curve  
A calibration curve was established using an isotropic-labeled internal standard. 
Calibration solutions were prepared by collaborators at NC State by diluting stock solutions of 
anthracene in acetone. Detailed solutions for each calibration solution are shown in Table 1.  
Table 1. Composition of calibration solution  
Concentration: 
ppm 
Internal 
standard: μL 
Analyte 
solution: μL 
Solvent: 
μL 
Total 
volume: μL 
10 200 10 790 1000 
20 200 20 780 1000 
50 200 50 750 1000 
100 200 100 700 1000 
150 200 150 650 1000 
200 200 200 600 1000 
QC-30 200 30 770 1000 
QC-120 200 120 680 1000 
The abundance ratio between peak m/z =152 (anthracene fragment) and m/z = 160 
(deuterated anthracene fragment, internal standard) was recorded and a calibration curve 
(Figure 1) was established based on the relationship between concentration and abundance 
ratio. 
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Figure 1 . Anthracene calibration curve from MS/MS with sample concentration 10-200 
ppm. 
 
3.3.3.2 Analysis of Human Test Samples 
Following the development of the calibration curve, the dialysate samples from the 
interstitial fluid were analyzed. Samples were extracted and analyzed by tandem mass 
spectrometry. 300 μL of HPLC grade acetone was added to the sample tube. The tube was 
then stirred by a VWR vortex mixer for 15 seconds at 2200 rpm and centrifuged by a VWR 
minicentrifuge for 15 seconds at 8000 rpm. Then the supernatant was taken and transferred 
into a 2 mL HPLC vial and mixed with 200 μL of 24 ppm D10-anthracene solution. Then the 
extracted and prepared sample was analyzed by the same instrument conditions used to 
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establish the calibration curve. The abundance ratio obtained on each sample was then used 
to calculate anthracene concentration using the equation of the calibration curve. Samples S1 
from all six test subjects were tested and the data were summarized in Table 2. 
Table 2. Tandem mass spectrometry data from human test samples 
Sample Name 
Abundance 
m/z 152       m/z 160 
Ratio 
152/160 
ppm concentration 
P2_S1_HOT 3404.6 5719.2 0.595 2.4 
P2_S1_TN 6073.9 5376.0 1.130 4.6 
P3_S1_HOT 6085.3 10421.7 0.584 2.4 
P3_S1_TN 5411.9 8723.0 0.620 2.5 
P4_S1_HOT 4726.9 10783.5 0.438 1.8 
P4_S1_TN 7309.2 11565.4 0.632 2.6 
P5_S1_HOT 6391.4 10347.2 0.618 2.5 
P5_S1_TN 5968.7 9589.7 0.622 2.5 
P6_S1_HOT 4850.9 5043.6 0.962 3.9 
P6_S1_TN 5771.4 8064.6 0.716 2.9 
P7_S1_HOT 5989.4 5429.3 1.103 4.5 
P7_S1_TN 2507.0 1746.3 1.436 5.9 
 
3.4 Pilot Testing 
In vitro Testing 
Vehicles for Delivery of Anthracene 
Substances that are lipophilic in structure were required for the mixing of ANT and 
successful delivery through the skin. Extensive pilot work was conducted using different 
vehicle solutions to dissolve and deliver ANT into the skin. Further pilot work was required 
for recovery of ANT via MD which is a sampling technique that is frequently used for the 
delivery or recovery of hydrophilic substances. This presented a challenge to both deliver and 
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recover ANT from interstitial fluid into the MD fiber due to its lipophilicity. The pilot work 
conducted to achieve delivery and recovery of ANT via MD is outlined below.  
3.4.1 Mineral Oil 
Mineral oil (MO) is a clear liquid distilled from petroleum used in cosmetic products 
that has been reported to permeate into the stratum corneum. Due to this reported absorption 
and lipophilicity, a 0.1% and 0.2% solution of ANT in MO was achieved. Mixtures of 0.5% or 
higher were attempted, however, the ANT would not dissolve in concentrations greater than a 
0.2% solution. MD fibers were submerged in petri dishes containing a 0.2% ANT in MO 
solution and equilibrated for 20 minutes to allow bidirectional exchange with the MD fiber 
(microperfusion pumps turned off). Dialysate samples were collected in a series of collection 
periods at a rate of 1 µL/min (Table 3) from 20-30 minutes, 40-70 minutes and 80-90 minutes 
following submersion. Between sample collection periods, pumps were turned off to allow 
equilibration between the ANT solution and MD fiber. Dialysate collections were then 
analyzed for the presence of ANT via fluorescence, as described in section 3.3.2. 
 
Equilibrium Collection Equilibrium Collection Equilibrium Collection Equilibrium 
20 min 10 min 10 min 30 min 20 min 10 min 20 min 
Table 3. In vitro Testing Protocol 
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3.4.2 DMSO  
Dimethyl-sulfoxide (DMSO) is a colorless liquid solvent that dissolves both polar and 
nonpolar compounds and has been utilized in previous MD studies as a vehicle solution (50). 
A solution of 0.2% and 0.5% ANT and 10% DMSO in MO was achieved. MD fibers were 
placed in petri dishes and collection was attempted as described above. Dialysate samples were 
not collected due to the 10% DMSO dissolving the MD membrane and preventing ANT 
recovery. DMSO was therefore not considered further for use in the study. 
 
3.4.3. Vaseline 
MO and DMSO proved unsuccessful as vehicle delivery solutions for ANT. Prior 
studies have developed fluorescent markers using anthracene and other PAHs in Vaseline, 
indicating that ANT can be adequately dissolved in Vaseline (29).  A 1% mixture of ANT in 
Vaseline was achieved and the mixture was placed on a heating plate with a magnetic stir bar 
and heated to 75o C at 30 rpm to ensure adequate mixing. A MD fiber was placed in a petri dish 
with the 1% solution of ANT in Vaseline and with LR solution at a rate of 1 µL/min. Dialysate 
samples were collected at 2 hours, 6 hours, and 20 hours following initial submersion to 
determine recovery over time and to establish suitable equilibration periods. Between sample 
collection periods, pumps were turned off to establish equilibration. These dialysate samples 
were then measured using fluorescence as described in section 3.3.2. With some success in 
recovering ANT from the MD fiber with a 1% solution, the same protocol was attempted with 
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a 2% solution of ANT in Vaseline. However, the 2% of ANT did not dissolve fully into the 
Vaseline. 
 
 
3.4.4. Aquaphor  
The Vaseline proved successful as a vehicle delivery solution for ANT, however, no 
solution higher than 1% was achieved. As another option for vehicle delivery of ANT, a 2% 
solution of ANT in Aquaphor, an over-the-counter skin care ointment, was created and mixed 
on a heating plate at 75o C at 30 rpm. A MD fiber was soaked in the 2% solution and dialysate 
collections, using the sample protocol as stated in the section of above, were examined via 
fluorescence described in section 3.3. 2. With detection of ANT with Aquaphor as a vehicle 
for delivery, Aquaphor was chosen as the vehicle for delivery and recovery of ANT. 
 
3.4.5. Solution and Perfusion Rate for Anthracene Recovery 
MD is a technique that is frequently utilized for the delivery or recovery of hydrophilic 
substances, the lipophilicity of the Aquaphor and ANT created challenges for successful 
recovery from the interstitial fluid. The perfusion rate of the microinfusion pumps determines 
the absolute and relative recovery of the dialysate, however higher perfusion rates create a back 
pressure that does not allow for substances in the interstitial fluid to freely move into the MD 
fiber. Pilot work using MO as the vehicle did not prove successful at a higher perfusion rate. 
Standard procedure for MD perfusion is typically 2 µL/min, but a rate of 1 µL/min was selected 
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based on pilot work with menthol from other labs (12). It was determined that an equilibration 
period (microinfusion pumps off) was necessary to permit bidirectional exchange between the 
interstitial fluid and the MD fiber.  Two MD fibers were soaked in a 0.2% solution of ANT in 
MO as described above, with the perfusion rates set at 0.5 µL/min and 1 µL/min. The dialysate 
was collected occurring to table 3 and analyzed with fluorescence. This analysis determined 
that a perfusion rate of 1 µL/min was the optimal perfusion rate for detection and recovery. 
3.5. In Vivo Testing  
In conjunction with extensive in vitro pilot work to establish and detection of ANT using 
intradermal microdialysis, in vivo pilot work was simultaneously completed in the ventral 
forearm. The protocol utilized for in vivo testing is outlined in figure 3 below. 
Fiber 
Insertion 
Hyperemia Anthracene 
Application 
Dialysate 
Collection 
Break Dialysate 
Collection 
Remove 
Fibers 
Wash 
and 
Check 
Sites 
20 min 45-60 min 15 min 1.5 hrs 2.5 
hrs 
1.5 hrs 15 min 10 
min  
Table 4. In vivo Testing Protocol. 
 
 
3.5.1. Mineral Oil 
To assess the delivery and recovery of ANT from the MD fibers in vivo, two MD fibers 
were inserted into the left ventral forearm. The 0.2% ANT solution in MO was applied directly 
to a 1 cm2 area of skin directly over the ANT MD site (see figure 2).  The protocol involving 
equilibration and dialysate sampling was conducting according to table 3 and then analyzed 
via fluorescence.  
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Figure 2. In vivo graphic showing a MD site in mineral oil applied to the 1 cm2 and covered 
with plastic wrap to prevent evaporation.  
 
3.5.2. Vaseline 
Fluorescence analysis did not indicate the presence of ANT in the dialysate of the in 
vivo 2% ANT in MO solution. With in vitro success indicating the presence of ANT in the 1% 
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ANT in Vaseline solution, a 1% ANT solution in Vaseline was applied directly to the skin as 
described above. Dialysate samples were collected according to table 4 and then analyzed via 
fluorescence.  
 
3.5.3 Aquaphor 
Based on in vitro success with ANT recovery, a 2% ANT in Aquaphor solution was 
applied directly to the skin over MD sites using the protocols outlined in section 3.5.1. 
Dialysate samples were collected according to the protocol outlined in Table 5 and then 
analyzed via fluorescence. The fluorescence analysis indicated the presence of ANT starting 
~3 hours after application on the skin, which informed the final protocol (there was no dialysate 
collection for the first 2½ hours) as indicated by the peaks at 398 nm and 420 nm in the 
fluorescence curves in figure 3.  
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Figure 3. Representative traces of fluorescence patterns from dialysate collection. Traces 
indicate the absence of anthracene in the sample using mineral oil, dimethyl sulfoxide, or 
Vaseline as the vehicle (A) or the presence of anthracene utilizing Aquaphor as a vehicle (B) 
with peaks at 398 nm and 420 nm. 
 
3.6. Experimental Protocols 
All study procedures were approved by the institutional review board at Appalachian 
State University and conformed to the guidelines set forth in the Declaration of Helsinki. 
Written and verbal consent was voluntarily obtained from all subjects before participation in 
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the study. The experiment was conducted in a group of six young, healthy subjects who were 
free from dermatological conditions.  
All experiments were conducted under thermoneutral conditions in the Thermal and 
Microvascular laboratory, Leon Levine Hall of Health Sciences.  Subjects arrived at the lab in 
a fasting state (12-hour fast) for completion of an informed consent and an initial screening 
visit. All subjects completed a medical history and measurements of anthropometrics (height 
and weight), blood pressure, heart rate, and a blood panel. All female subjects had a negative 
urine pregnancy test for participation in the study. After screening, subjects attended the 
laboratory on a separate day for completion of the experimental testing. Subjects refrained 
from alcohol, caffeine, and intense exercise for 12 hours prior to the study.  The 2% ANT in 
Aquaphor solution was mixed prior to the experiment whereby Aquaphor was heated at 70 °C 
for 5 minutes before ANT was added. The chemicals were mixed using a magnetic stir bar on 
a heating stirring plate for another 10 minutes before being weighed, with 0.2 g required for 
each site. The ANT solution was covered with foil and protected from sunlight until use. 
applied. Upon arrival to the laboratory MD insertion sites were marked on the left ventral 
forearm, sterile technique was utilized, and MD fibers were inserted as described in section 
3.3.1. Two intradermal microdialysis fibers (30 kDa cutoff; MD 2000, LM-10, Bioanalytical 
Systems) were placed in the skin of the ventral surface of the forearm separated by at least 2 
cm to prevent cross reactivity. Entry and exit points were covered with a small piece of tape to 
prevent ANT contamination beneath the skin. A 1 cm2 template was used to create an isolated 
surface area of the skin for ANT cream placement. After fiber placement, 0.2 g of the 2% ANT 
in Aquaphor was applied to the skin over each MD fiber site. Subjects were then outfitted with 
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LH units (Moor Instruments, UK) and laser doppler probes to measure red blood cell flux 
(Moor Instruments)). After instrument implementation, a 10% HBC in lactated Ringer’s 
solution was perfused through all sites at a rate of 1 μl/min (BASi Bee Hive controller and 
Baby Bee syringe drive). Heart rate and blood pressure were measured every 5 minutes 
throughout the protocol via brachial auscultation. A series of dialysate collections were 
performed using the outline as described in Table 3. All samples were collected, labeled and 
refrigerated before being sent to collaborators at North Carolina State University for analysis 
using MS.  
Tsk was clamped at 33° C at both sites for 10 minutes and dialysate samples were 
collected during a thermoneutral baseline. One site (sites were randomized to counterbalance 
skin temperature site) was set to clamp Tsk at 43° C for a heating blood flow baseline. Both 
sites were clamped throughout the protocol. The experimental protocol was structured 
similarly to the outline in figure 3 in section 3.5. After ANT application, the MD fibers were 
perfused with a 10% 2 hydroxypropyl-beta-cyclodextrin in Lactated Ringer’s solution for 90 
minutes. A series of collections were performed starting 2 hours after the ANT application. 
After a 15-minute collection period, pumps were turned off for a 30-minute equilibration 
period. This procedure was followed for three sample collection periods. At the end of the 
collection period, the LH unit over the thermoneutral site was raised to 43° C and 56 mM 
sodium nitroprusside was perfused through the fibers at both MD sites at a rate of 4 µL/min to 
obtain maximal cutaneous vasodilation.  
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3.7. Data and Statistical Analysis 
Red blood cell flux was digitized and recorded at 40 Hz for later offline analysis using 
Windaq software and Dataq data acquisition system (Windaq: Dataq Instruments, Arkon, OH). 
A five-minute average of LDF data was measured during each sample collection period and 
cutaneous vascular conductance (CVC; LDF/MAP) was calculated. Data for a percentage of 
CVC maximum (%CVCmax) were measured by averaging LDF values from a sixty second 
plateau obtained during 56 mM SNP perfusions and simultaneous 43° C heating 
((CVC/CVCmax) *100). A two-tailed t-test was performed in SigmaPlot to determine 
significance (α = .05; n = 6) and presented as mean +/- standard error.  All descriptive subject 
characteristics were expressed as mean +/- standard error.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
Chapter 4 
Results 
Subject characteristics for the six (5 male, 1 female) healthy subjects that completed the 
experimental protocol are presented in table 5.  
 
Table 5. Subject characteristics. 
 
 Mean Standard Error of the Mean 
Age 32.0 4.9 
Height (cm) 162.7 10.7 
Weight (kg) 91.3 17.7 
RHR 64.2 5.3 
SBP (mmHg) 130 4 
DBP (mmHg) 74 3 
Glucose (mg/dL) 93.8 4.7 
HDL (mg/dL) 56.8 9.1 
LDL (mg/dL) 118 10.1 
Trigs (mg/dL) 141.7 26.0 
TC (mg/dL) 186.3 18.0 
Anthracene concentration (ppm) in the dialysate samples was similar between the hot 
and thermoneutral sites (P=0.263), with values of 2.9 ± 0.4 and 3.5 ± 0.4 respectively (Figure 
4). Absolute red blood cell flux (LDF) and cutaneous vascular conductance (%CVCmax) are 
illustrated in figure 5. Absolute SkBF was significantly higher at the heated versus the 
thermoneutral site (P=0.001) with values of 35.7 ± 11.8 and 7.2 ± 1.0, respectively. Values 
were not significantly different between sites when presented as %CVCmax (P=0.057) with 
values of 29.2 ± 8.3 and 8.6 ± 2.3, respectively.  
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Figure 4. Anthracene concentration in dialysate samples expressed in parts per million (ppm) 
at the thermoneutral (TN) and hot sites collected between 2h30 min and 2h45 min following 
dermal anthracene application. No significant differences were observed between sites 
(P>0.05; n = 6). 
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Figure 5.  Skin blood flow expressed as (A) absolute LDF and (B) normalized to maximum 
vasodilation (%CVC) during the sample collection period. Maximum LDF was significantly 
higher in the heated site (P=0.001) 0.05; n = 6). *** P ≤ 0.001. 
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Chapter 5 
Discussion 
A major finding in this study was that microdialysis can be successfully used to recover 
the PAH anthracene following dermal application in vivo. This finding is methodologically 
important for the development of a protocol that allows for continuous sampling of dermal 
absorption with microdialysis, coupled with the measurement of anthracene with MS. While 
many studies have examined the deposition of PAHs on the skin of firefighters and other 
occupational groups, to our knowledge, this is the first protocol to examine dermal absorption 
of a PAH in vivo using MD. In accordance with our findings, studies have shown that small 
concentrations of these PAHs could be absorbed through the skin by assessing biological 
markers following environmental exposure, including fire suppression and charcoal grilling 
(64). Dermal tape stripping and dermal swabs have shown the presence of PAH particulates 
on the skin of workers exposed to these PAHs and urine analysis of PAH metabolites indicate 
a route of exposure of these PAHs, whether it be respiratory or dermal.  Similarly, in vivo 
modeling studies used surface disappearance of dermally applied PAHs and 1-OH-pyrene 
excretion measurement to estimate differences in dermal PAH absorption (57). Recently, ex 
vivo human skin modeling found that benzo [a] pyrene was absorbed into the skin and its 
metabolites could be measured using high-performance liquid chromatography (8). While 
numerous studies have assessed the exposure to these toxic PAHs released during incomplete 
combustion with biological monitoring, including breath, urine, and dermal sampling, the 
intradermal sampling technique of MD allowed for the recovery of ANT directly from the 
interstitial fluid, directly demonstrating dermal absorption.   
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 Anthracene was detected in both sample sites following 2 h 30 minutes of exposure in 
all subjects, but the amount of ANT recovered between the heated and thermoneutral sites was 
similar. This finding was contrary to our hypothesis since substantial evidence suggests there 
is greater dermal absorption of a wide range of transdermal products at higher temperatures. 
This has been observed in pharmacological studies aiming to improve dermal drug delivery, 
for example, the assessment of differences in serum concentrations of testosterone after the 
application of a heat-generating patch (45). Authors observed both maximum peak and area 
under the curve plasma testosterone was significantly higher in the group with the heated patch 
vs a thermoneutral control (46). Similarly, the effects of local heating on the systemic delivery 
of fentanyl from a  CHADD patch has been assessed in multiple studies (20, 33, 46). The 
CHADD patch increased skin temperature to 41 ± 1°C and resulted in shortened peak serum 
fentanyl concentrations as well as increases in the total concentration of fentanyl (1, 46). Some 
literature remains inconsistent with the measurement of these transdermal drug delivery 
systems in vivo as many methods, such as exercise and increased ambient temperature, did not 
include a precise, controlled skin temperature measurement (2, 56). Nevertheless, much of the 
literature indicates that increased skin temperature from locally applied heat should increase 
the amount of anthracene recovered.  
 In the present study, one potential explanation for the similarity in ANT concentration 
between sites may be the significantly different skin blood flows. The LDF was significantly 
higher in the heated site which may have impacted the clearance of the interstitial fluid causing 
the anthracene to move away from the microdialysis membrane. In a study that investigated 
local blood flow on the recovery of sodium fluorescein via microdialysis in vivo, local 
vasodilation decreased the amount of fluorescein by approximately 50% (11). Recovery was 
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also increased at vasoconstricted sites suggesting that the recovery of a substance from a 
microdialysis probe will be directly impacted by the clearance of that substance. In conjunction 
with decreased recovery from increased clearance, the clearance rate of the substance is 
proportional to the blood flow around the MD pump (11). This may explain the similar 
concentration of anthracene recovered in the heated compared to the control site. Sampling via 
intradermal MD can be influenced by multiple factors and does not strictly measure dermal 
absorption directly. Recovery via MD does not fully reflect dermal absorption and therefore 
further work is needed to elucidate the effects of skin temperature on the dermal absorption of 
PAHs. Future studies should examine the effect of controlling skin blood flow beneath each 
MD fiber so that the effect of dermal absorption can be more fully elucidated without increased 
clearance as a confounding factor. Epinephrine has been observed to prolong the sensory 
blocking effects on anesthetics by slowing the clearance of these substances away from the site 
(5), and warrant further investigation.  
 Increases in dermal clearance due to higher blood flow may explain the similarity in 
the concentration of anthracene recovered from each site. Nevertheless, the successful recovery 
of a PAH such as anthracene through microdialysis has important practical applications. It is 
widely recognized that firefighters and other occupational groups such as coal tar workers and 
asphalt workers are exposed to these hazardous chemicals (7, 52). Respiratory routes of 
exposure are more commonly studied in the field, but deposition of PAHs on the clothing and 
skin of these workers are recognized. Currently, the overall contribution of dermal absorption 
to overall exposure is not known and may be underestimated. With the development of the 
present protocol, the amount of dermal absorption over time may be better assessed in the field 
during occupational exposure. Future studies could use this protocol to examine how dermal 
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PAH exposure contributes to the overall exposure of firefighters to carcinogens during fire 
suppression. Improving our understanding of dermal exposure and absorption may have 
greater relevance to consideration of the personal protective clothing worn by firefighters and 
other occupational groups during exposure to these harmful chemicals to ensure greater safety. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36 
References 
1. Ashburn MA, Ogden LL, Zhang J, Love G, and Basta SV. The pharmacokinetics 
of transdermal fentanyl delivered with and without controlled heat. J Pain 4: 291-297, 2003. 
2. Barkve TF, Langseth-Manrique K, Bredesen JE, and Gjesdal K. Increased uptake 
of transdermal glyceryl trinitrate during physical exercise and during high ambient 
temperature. Am Heart J 112: 537-541, 1986. 
3. Baxter CS, Hoffman JD, Knipp MJ, Reponen T, and Haynes EN. Exposure of 
Firefighters to Particulates and Polycyclic Aromatic Hydrocarbons. Journal of occupational 
and environmental hygiene 11: D85-D91, 2014. 
4. Beckley-Kartey SA, Hotchkiss SA, and Capel M. Comparative in vitro skin 
absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. Toxicol 
Appl Pharmacol 145: 34-42, 1997. 
5. Bernards CM, and Kopacz DJ. Effect of epinephrine on lidocaine clearance in vivo: 
a microdialysis study in humans. Anesthesiology 91: 962-968, 1999. 
6. Boes KS, Roberts MS, and Vinueza NR. Rapid Quadrupole-Time-of-Flight Mass 
Spectrometry Method Quantifies Oxygen-Rich Lignin Compound in Complex Mixtures. J 
Am Soc Mass Spectrom 29: 535-542, 2018. 
7. Bolstad-Johnson DM, Burgess JL, Crutchfield CD, Storment S, Gerkin R, and 
Wilson JR. Characterization of firefighter exposures during fire overhaul. Aihaj 61: 636-641, 
2000. 
8. Bourgart E, Barbeau D, Marques M, von Koschembahr A, Beal D, Persoons R, 
Leccia MT, Douki T, and Maitre A. A realistic human skin model to study benzo[a]pyrene 
 37 
cutaneous absorption in order to determine the most relevant biomarker for carcinogenic 
exposure. Arch Toxicol 93: 81-93, 2019. 
9. Charkoudian N. Mechanisms and modifiers of reflex induced cutaneous vasodilation 
and vasoconstriction in humans. Journal of Applied Physiology 109: 1221-1228, 2010. 
10. Charkoudian N. Skin blood flow in adult human thermoregulation: How it works, 
when it does not, and why. Mayo Clinic Proceedings 78: 603-612, 2003. 
11. Clough GF, Boutsiouki P, Church MK, and Michel CC. Effects of blood flow on 
the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J 
Pharmacol Exp Ther 302: 681-686, 2002. 
12. Craighead DH, and Alexander LM. Menthol-Induced Cutaneous Vasodilation Is 
Preserved in Essential Hypertensive Men and Women. Am J Hypertens 30: 1156-1162, 2017. 
13. Craighead DH, Smith CJ, and Alexander LM. Blood pressure normalization via 
pharmacotherapy improves cutaneous microvascular function through NO-dependent and 
NO-independent mechanisms. Microcirculation (New York, NY : 1994) 24: 2017. 
14. Daniels RD, Kubale TL, Yiin JH, Dahm MM, Hales TR, Baris D, Zahm SH, 
Beaumont JJ, Waters KM, and Pinkerton LE. Mortality and cancer incidence in a pooled 
cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950–2009). 
Occupational and environmental medicine 71: 388-397, 2014. 
15. Ebah L, Brenchley P, Coupes B, and Mitra S. A Modified in vivo Flow Variation 
Technique of Microdialysis for Sampling Uremic Toxins in the Subcutaneous Interstitial 
Compartment. Blood Purification 32: 96-103, 2011. 
 38 
16. Elias PM, Holleran WM, Feingold KR, Tsai J, and Menon GK. The Potential of 
Metabolic Interventions to Enhance Transdermal Drug Delivery. Journal of Investigative 
Dermatology Symposium Proceedings 7: 79-85, 2002. 
17. Fent KW, Eisenberg J, Snawder J, Sammons D, Pleil JD, Stiegel MA, Mueller C, 
Horn GP, and Dalton J. Systemic Exposure to PAHs and Benzene in Firefighters 
Suppressing Controlled Structure Fires. The Annals of Occupational Hygiene 58: 830-845, 
2014. 
18. Gordon SM, Wallace LA, Callahan PJ, Kenny DV, and Brinkman MC. Effect of 
water temperature on dermal exposure to chloroform. Environ Health Perspect 106: 337-345, 
1998. 
19. Habicht SC, Duan P, Vinueza NR, Fu M, and Kenttamaa HI. Liquid 
chromatography/tandem mass spectrometry utilizing ion-molecule reactions and collision-
activated dissociation for the identification of N-oxide drug metabolites. J Pharm Biomed 
Anal 51: 805-811, 2010. 
20. Hao J, Ghosh P, Li SK, Newman B, Kasting GB, and Raney SG. Heat effects on 
drug delivery across human skin. Expert opinion on drug delivery 13: 755-768, 2016. 
21. Haynes HJG, and Stein GP. U.S. Fire Department Profile - 2015. National Fire 
Protection Association April 2017. 
22. Hocht C, Opezzo JA, and Taira CA. Microdialysis in drug discovery. Curr Drug 
Discov Technol 1: 269-285, 2004. 
23. Hutchinson PJ, Jalloh I, Helmy A, Carpenter KLH, Rostami E, Bellander B-M, 
Boutelle MG, Chen JW, Claassen J, Dahyot-Fizelier C, Enblad P, Gallagher CN, 
Helbok R, Hillered L, Le Roux PD, Magnoni S, Mangat HS, Menon DK, Nordström C-
 39 
H, O’Phelan KH, Oddo M, Perez Barcena J, Robertson C, Ronne-Engström E, 
Sahuquillo J, Smith M, Stocchetti N, Belli A, Carpenter TA, Coles JP, Czosnyka M, 
Dizdar N, Goodman JC, Gupta AK, Nielsen TH, Marklund N, Montcriol A, O’Connell 
MT, Poca MA, Sarrafzadeh A, Shannon RJ, Skjøth-Rasmussen J, Smielewski P, Stover 
JF, Timofeev I, Vespa P, Zavala E, and Ungerstedt U. Consensus statement from the 2014 
International Microdialysis Forum. Intensive Care Medicine 41: 1517-1528, 2015. 
24. IARC. Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum 
98: 9-764, 2010. 
25. IARC. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related 
exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 92: 2010. 
26. Jahnke SA, Poston WSC, Jitnarin N, and Haddock CK. Health Concerns of the 
U.S. Fire Service: Perspectives From the Firehouse. American journal of health promotion : 
AJHP 27: 111-118, 2012. 
27. Kalia YN, Naik A, Garrison J, and Guy RH. Iontophoretic drug delivery. 
Advanced Drug Delivery Reviews 56: 619-658, 2004. 
28. Klemsdal TO, Gjesdal K, and Zahlsen K. Physical exercise increases plasma 
concentrations of nicotine during treatment with a nicotine patch. British Journal of Clinical 
Pharmacology 39: 677-679, 1995. 
29. Kurata S, Hirano H, and Nagai M. Development of fluorescent markers using 
polycyclic aromatic hydrocarbons with vaseline. J Forensic Sci 47: 244-253, 2002. 
30. Larsen B, Snow R, Williams-Bell M, and Aisbett B. Simulated Firefighting Task 
Performance and Physiology Under Very Hot Conditions. Front Physiol 6: 322, 2015. 
 40 
31. LeMasters GK, Genaidy AM, Succop P, Deddens J, Sobeih T, Barriera-Viruet 
H, Dunning K, and Lockey J. Cancer risk among firefighters: a review and meta-analysis of 
32 studies. J Occup Environ Med 48: 1189-1202, 2006. 
32. Mark R Prausnitz PME, Thomas J Franz, Matthias Schmuth, Jui-Chen Tsai, 
Copinathan K Menon, Walter M Holleran, Kenneth R Feingold. Skin Barrier and 
Transdermal Drug Delivery. In: Medical Therapy2010. 
33. Marriott TB, Charney MR, and Stanworth S. Effects of Application Durations and 
Heat on the Pharmacokinetic Properties of Drug Delivered by a Lidocaine/Tetracaine Patch: 
A Randomized, Open-Label, Controlled Study in Healthy Volunteers. Clinical Therapeutics 
34: 2174-2183, 2012. 
34. Menon GK, Kollias N, and Doukas AG. Ultrastructural Evidence of Stratum 
Corneum Permeabilization Induced by Photomechanical Waves. Journal of Investigative 
Dermatology 121: 104-109, 2003. 
35. Morgan CJ, Renwick AG, and Friedmann PS. The role of stratum corneum and 
dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs 
investigated by microdialysis. Br J Dermatol 148: 434-443, 2003. 
36. Otto DP, and de Villiers MM. The Experimental Evaluation and Molecular 
Dynamics Simulation of a Heat-Enhanced Transdermal Delivery System. AAPS 
PharmSciTech 14: 111-120, 2013. 
37. Park J-H, Lee J-W, Kim Y-C, and Prausnitz MR. The effect of heat on skin 
permeability. International journal of pharmaceutics 359: 94-103, 2008. 
 41 
38. Petersen KK, Rousing ML, Jensen C, Arendt-Nielsen L, and Gazerani P. Effect 
of local controlled heat on transdermal delivery of nicotine. International Journal of 
Physiology, Pathophysiology and Pharmacology 3: 236-242, 2011. 
39. Plock N, and Kloft C. Microdialysis—theoretical background and recent 
implementation in applied life-sciences. European Journal of Pharmaceutical Sciences 25: 
1-24, 2005. 
40. Prausnitz MR, and Langer R. Transdermal drug delivery. Nature biotechnology 26: 
1261-1268, 2008. 
41. Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir 
L, Sparen P, and Demers PA. Cancer incidence among firefighters: 45 years of follow-up 
in five Nordic countries. Occup Environ Med 71: 398-404, 2014. 
42. Raines J, Snow R, Nichols D, and Aisbett B. Fluid intake, hydration, work 
physiology of wildfire fighters working in the heat over consecutive days. The Annals of 
Occupational Hygiene 59: 554-565, 2015. 
43. Scheuplein RJ, and Blank IH. Permeability of the skin. Physiological Reviews 51: 
702-747, 1971. 
44. Shahzad Y, Louw R, Gerber M, and du Plessis J. Breaching the skin barrier 
through temperature modulations. J Control Release 202: 1-13, 2015. 
45. Shomaker TS, Zhang J, and Ashburn MA. A pilot study assessing the impact of 
heat on the transdermal delivery of testosterone. J Clin Pharmacol 41: 677-682, 2001. 
46. Shomaker TS, Zhang J, and Ashburn MA. Assessing the impact of heat on the 
systemic delivery of fentanyl through the transdermal fentanyl delivery system. Pain Med 1: 
225-230, 2000. 
 42 
47. Sides CR, and Stenken JA. Microdialysis Sampling Techniques Applied to Studies 
of the Foreign Body Reaction. European journal of pharmaceutical sciences : official 
journal of the European Federation for Pharmaceutical Sciences 57: 74-86, 2014. 
48. Smith CJ, Craighead DH, and Alexander LM. Effects of vehicle microdialysis 
solutions on cutaneous vascular responses to local heating. Journal of Applied Physiology 
123: 1461-1467, 2017. 
49. Smith CJ, and Havenith G. Body mapping of sweating patterns in male athletes in 
mild exercise-induced hyperthermia. Eur J Appl Physiol 111: 1391-1404, 2011. 
50. Smith CJ, Santhanam L, Bruning RS, Stanhewicz A, Berkowitz DE, and 
Holowatz LA. Upregulation of iNOS contributes to attenuated cutaneous vasodilation in 
essential hypertensive humans. Hypertension 58: 935-942, 2011. 
51. Stanhewicz AE, Bruning RS, Smith CJ, Kenney WL, and Holowatz LA. Local 
tetrahydrobiopterin administration augments reflex cutaneous vasodilation through nitric 
oxide-dependent mechanisms in aged human skin. Journal of applied physiology (Bethesda, 
Md : 1985) 112: 791-797, 2012. 
52. Sun XC, Zhang F, Zhang W, Lu CD, Zhang ZH, Feng B, Wei HY, Meng X, 
Chen XL, Shao H, and Wang ZX. [The effect of occupational exposure to coal tar pitch 
workers' health]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 34: 827-829, 2016. 
53. Tominaga K, and Tojo K. Effect of environmental temperature on transdermal drug 
penetration. Biol Pharm Bull 33: 1983-1987, 2010. 
54. Trabaris M, Laskin JD, and Weisel CP. Effects of temperature, surfactants and 
skin location on the dermal penetration of haloacetonitriles and chloral hydrate. J Expo Sci 
Environ Epidemiol 22: 393-397, 2012. 
 43 
55. Tsai RJ, Luckhaupt SE, Schumacher P, Cress RD, Deapen DM, and Calvert 
GM. Risk of cancer among firefighters in California, 1988-2007. Am J Ind Med 58: 715-729, 
2015. 
56. Vanakoski J, Seppala T, Sievi E, and Lunell E. Exposure to high ambient 
temperature increases absorption and plasma concentrations of transdermal nicotine. Clin 
Pharmacol Ther 60: 308-315, 1996. 
57. VanRooij JGM, De Roos JHC, Bodelier‐Bade MM, and Jongeneelen FJ. 
Absorption of polycyclic aromatic hydrocarbons through human skin: Differences between 
anatomical sites and individuals. Journal of Toxicology and Environmental Health 38: 355-
368, 1993. 
58. Wick AF, Haus NW, Sukkariyah BF, Haering KC, and Daniels WL. Remediation 
of PAH-contaminated soils and sediments: a literature review. CSES Department, internal 
research document 102: 2011. 
59. Willi JM, Horn GP, and Madrzykowski D. Characterizing a Firefighter’s 
Immediate Thermal Environment in Live-Fire Training Scenarios. Fire Technology 52: 
1667-1696, 2016. 
60. Williams AC, and Barry BW. Penetration enhancers. Advanced Drug Delivery 
Reviews 56: 603-618, 2004. 
61. Wilson SC, and Jones KC. Bioremediation of soil contaminated with polynuclear 
aromatic hydrocarbons (PAHs): a review. Environmental pollution 81: 229-249, 1993. 
62. Wingfors H, Nyholm JR, Magnusson R, and Wijkmark CH. Impact of Fire Suit 
Ensembles on Firefighter PAH Exposures as Assessed by Skin Deposition and Urinary 
Biomarkers. Ann Work Expo Health 62: 221-231, 2018. 
 44 
63. Wood DG, Brown MB, and Jones SA. Understanding heat facilitated drug transport 
across human epidermis. European Journal of Pharmaceutics and Biopharmaceutics 81: 
642-649, 2012. 
64. Wu CC, Bao LJ, Guo Y, Li SM, and Zeng EY. Barbecue Fumes: An Overlooked 
Source of Health Hazards in Outdoor Settings? Environ Sci Technol 49: 10607-10615, 2015. 
65. Zhang Q, Murawsky M, LaCount T, Hao J, Kasting GB, Newman B, Ghosh P, 
Raney SG, and Li SK. Characterization of Temperature Profiles in Skin and Transdermal 
Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro. 
Pharmaceutical Research 34: 1491-1504, 2017. 
 
 
 
 
 
 
 
 
 
 
 
 45 
 
 
 
 
 
Vita 
 Killian Drake Wustrow was born in Siler City, North Carolina to Klaus and Susan 
Wustrow. He graduated from Chatham Central High School in 2013. The following autumn, 
he entered Wake Forest University to study Health and Exercise Science, and in 2017 he was 
awarded the Bachelor of Science degree. In the fall of 2017, he accepted a graduate 
assistantship in Exercise Science at Appalachian State University and began study toward a 
Master of Science degree. The M.S. was awarded in August 2019.  
 
